You Searched For "stocks and covid" and got 18 results
Sort By:
2 mins read
Global stocks trade at record highs on vaccine hopes and chances of fresh US stimulus
A series of rolling blackouts took around 1 million barrels of oil production offline and closed re…
Shalini Nagarajan
2 mins read
Moderna soars 16% after announcing plans to file for emergency use authorization as results indicate its COVID-19 vaccine is 94% effective
Moderna said the vaccine was more than 94% effective at preventing people in its late-stage trial f…
Shalini Nagarajan
2 mins read
Moderna, BioNtech surge as COVID-19 vaccine development progresses amid virus spike
BioNtech and Pfizer have already produced millions of doses of its vaccine so it can deliver on pre…
Matthew Fox
1 min read
Energy stocks plummet amid oil sell-off driven by threats of boosted production
The National Oil Corporation of Libya said it would double its production to 1 million barrels per …
Matthew Fox
2 mins read
Global stocks rise ahead of a $908 billion pandemic relief bill reaching Congress and the US rolls out the first COVID-19 vaccines
US lawmakers plan to divide the coronavirus relief plan into two proposals in order to be voted on …
Shalini Nagarajan
2 mins read
Chinese stocks look ready to outperform with COVID-easing catalysts on deck, Europe's top asset manager says
Amundi, which oversees more than $2 trillion in assets, is now bullish on Chinese stocks after cutt…
Hamza Fareed Malik
1 min read
Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdowns
The stock prices of vaccine makers Moderna and Pfizer surged Friday along with stay-at-home stocks …
Isabelle Lee
2 mins read
US stocks hover near record highs at the start of the 2nd half of 2021, but the Delta variant knocks Asian equities and boosts the dollar
The Delta variant spread doesn't pose a direct risk to equities, and could instead drive a rebound …
Shalini Nagarajan
3 mins read
A prolonged COVID-19 pandemic could lead to a sharp correction in the stock market, IMF warns
"If the economic recovery is delayed, there is a risk of a sharp adjustment in asset prices or peri…
Matthew Fox
1 min read
Novavax surges 15% after it begins phase 3 trial of COVID-19 vaccine
In the scenario that Novavax succeeds in developing a successful COVID-19 vaccine candidate, it is …
Matthew Fox
2 mins read
Global stocks gain after US lawmakers inch closer toward compromise on a $908 billion coronavirus relief plan
Senate Leader Mitch McConnell is "heartened" that Democrats are stepping away from the $2.4 trillio…
Shalini Nagarajan
2 mins read
US futures edge lower as atrocities in Ukraine raise the chances of more sanctions on Russia, while inflation concerns persist
Equities were muted, with several Fed speakers due to talk later, concern lingering over inflation …
Adam Morgan McCarthy
2 mins read
Here's when coronavirus vaccines will be rolled out in advanced economies, according to Goldman Sachs
More than 70% of people in developed economies can expect to be immunized by fall 2021, economists …
Shalini Nagarajan
2 mins read
Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.
Bancel sold a total of 19,000 shares between November 18-19 as part of a predetermined trading plan…
Shalini Nagarajan
2 mins read
Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial
The 52-week high for Pfizer stock is $41.99, which means CEO Albert Bourla sold his shares at close…
Shalini Nagarajan
2 mins read
US stocks head for 7th day of record highs, while oil tops $75 for the first time since 2018
Markets have got off to a strong start at the halfway point in the year, with risk assets resuming …
Shalini Nagarajan
1 min read
AstraZeneca slides after announcing its COVID-19 vaccine candidate is 70% effective
The Oxford/AstraZeneca vaccine is cheaper to produce than Pfizer and Moderna's, but is clearly less…
Shalini Nagarajan
2 mins read
Sell stocks into strength on any COVID-19 vaccine news as 2021 turns into a bear market, BofA says
The good news for investors is that opportunities will persist despite a potentially weak stock mar…